Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Rolfe Lindsey converted options into 8,374 shares and sold $8,376 worth of shares (4,252 units at $1.97), increasing direct ownership by 4% to 100,604 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.

SEC Form 4: Rolfe Lindsey converted options into 8,374 shares and sold $8,376 worth of shares (4,252 units at $1.97), increasing direct ownership by 4% to 100,604 units (withholding tax) | Quantisnow